
Quinovic acid 3-O-rhamnoside | CAS:104055-76-7
Quinovic acid 3-O-rhamnoside
- Name:Quinovic acid 3-O-rhamnoside
- CAS:104055-76-7
- Synonyms:
- Molecular Formula:C36H56O9
- Molecular Weight:632.84
- EINESC:
Description
Properties
没有数据 | 没有数据 |
---|
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Poly(methyl vinyl ether-co-maleic acid)-polyethylene glycol nanocomposites cross-linked in situ with cellulose nanowhiskers.Lee Goetz et al.Biomacromolecules, 11(10), 2660-2666 (2010-09-23)
A multi-tasking dentifrice for the 21st century.Serge Dibart et al.American journal of dentistry, 24 Spec No A, 3A-5A (2012-01-06)
Extrinsic stain removal efficacy of a new dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica for sensitivity relief and whitening benefits as compared to a dentifrice containing 0.3% triclosan, 2% PVM/MA copolymer, 0.243% NaF and to a negative control dentifrice containing 0.243% NaF: a 6-week study.Salim Nathoo et al.American journal of dentistry, 24 Spec No A, 28A-31A (2012-01-06)
Final report of the Amended Safety Assessment of PVM/MA copolymer and its related salts and esters as used in cosmetics.Christina L Burnett et al.International journal of toxicology, 30(5 Suppl), 128S-144S (2011-11-30)
A comparison of the efficacy of a triclosan/copolymer/sodium fluoride dentifrice, a stannous fluoride/sodium hexametaphosphate/zinc lactate dentifrice, and a sodium fluoride dentifrice for the control of established supragingival plaque and gingivitis: a six-week clinical study.Farid Ayad et al.The Journal of clinical dentistry, 21(4), 111-116 (2011-01-29)
Capture of infectious borna disease virus using anionic polymer-coated magnetic beads.Akikazu Sakudo et al.Neuroscience letters, 494(3), 237-239 (2011-03-17)
Comparative investigation of the efficacy of triclosan/copolymer/sodium fluoride and stannous fluoride/sodium hexametaphosphate/zinc lactate dentifrices for the control of established supragingival plaque and gingivitis in a six-month clinical study.Augusto Elias Boneta et al.The Journal of clinical dentistry, 21(4), 117-123 (2011-01-29)
A dentifrice with multiple benefits.Franklin García-Godoy American journal of dentistry, 24 Spec No A, 2A-2A (2012-01-06)
High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide.Elisa Elizondo et al.Pharmaceutical research, 28(2), 309-321 (2010-12-03)
Comparison of the short-term antiplaque/antibacterial efficacy of two commercial dentifrices.Virginia Monsul Barnes et al.The Journal of clinical dentistry, 21(4), 101-104 (2011-01-29)
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators.A I Camacho et al.Vaccine, 29(41), 7130-7135 (2011-06-10)
The effect of denture design and fixatives on the retention of mandibular complete dentures tested on a novel in-vitro edentulous model.A Johnson et al.The European journal of prosthodontics and restorative dentistry, 21(2), 64-74 (2013-07-31)
The response of subcutaneous connective tissue to newly developed calcium phosphate-based root canal sealers.R M Khashaba et al.International endodontic journal, 44(4), 342-352 (2011-01-29)
The effect of denture adhesives on Candida albicans growth in vitro.Benedita Sampaio-Maia et al.Gerodontology, 29(2), e348-e356 (2011-04-05)
Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.Katarzyna Migalska et al.Pharmaceutical research, 28(8), 1919-1930 (2011-03-26)
A clinical investigation of the efficacy of three commercially available dentifrices for controlling established gingivitis and supragingival plaque.Surrendra Singh et al.The Journal of clinical dentistry, 21(4), 105-110 (2011-01-29)
Anti-hypersensitivity mechanism of action for a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica.Lynette Zaidel et al.American journal of dentistry, 24 Spec No A, 6A-13A (2012-01-06)
Using DGGE and 16S rRNA gene sequence analysis to evaluate changes in oral bacterial composition.Zhou Chen et al.The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA), 14(2), 95-103 (2012-02-10)
Synthesis of microwave-assisted poly(methyl vinyl ether-co-maleic anhydride)-bovine serum albumin bioconjugates.Mesut Karahan et al.Artificial cells, blood substitutes, and immobilization biotechnology, 40(6), 363-368 (2012-05-01)
Assessment of hypersensitivity reduction of a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica as compared to a dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate and zinc lactate and to a dentifrice containing 0.243% NaF on dentin hypersensitivity reduction: an 8-week study.Patricia Chaknis et al.American journal of dentistry, 24 Spec No A, 14A-20A (2012-01-06)
Evaluation of the antimicrobial activity of dentifrices on human oral bacteria.Violet I Haraszthy et al.The Journal of clinical dentistry, 21(4), 96-100 (2011-01-29)
Superior management of plaque and gingivitis through the use of a triclosan/copolymer dentifrice.Sebastian Ciancio et al.The Journal of clinical dentistry, 21(4), 93-95 (2011-01-29)
Effects of dentin tubule occlusion by dentifrice containing a PVM/MA bioadhesive copolymer in a silica base.Xuejun Liu et al.Journal of dentistry, 39(4), 293-301 (2010-11-09)
Comparative investigation of a dentifrice containing triclosan/copolymer/sodium fluoride and specially-designed silica and a dentifrice containing 0.243% sodium fluoride in a silica base for the control of established supra-gingival plaque and gingivitis: a 6-month clinical study.Suru Mankodi et al.American journal of dentistry, 24 Spec No A, 21A-27A (2012-01-06)
Controlling biofilm with evidence-based dentifrices.Sebastian G Ciancio Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 32(1), 70-76 (2011-04-06)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!